Every 10-Q that Carter Bankshares, Inc. (CARE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CARE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CARE filings page.
Carter Bankshares, Inc. reported net income of $28,911 thousand for the quarter ended June 30, 2026, up from $8,510 thousand a year earlier, and $114,668 thousand for the first six months versus $17,463 thousand in 2025. Basic and diluted EPS were $1.31 for the quarter and $5.18 year‑to‑date. Net interest income reached $39,950 thousand for the quarter and $75,884 thousand for six months, while noninterest income was lifted by a $35,949 thousand gain on an insurance transaction and a $65,000 thousand gain on a loan sale transaction, partly offset by $12,451 thousand of losses on securities sales.
Total assets were $4,801,883 thousand at June 30, 2026. Portfolio loans declined to $3,734,594 thousand, reflecting sale of the bank’s largest problem credit, while cash and cash equivalents increased to $276,535 thousand. Total deposits were $4,197,556 thousand, and Federal Home Loan Bank borrowings fell to zero from $178,500 thousand at year‑end. Asset quality improved markedly: nonperforming loans dropped to $37,561 thousand from $243,982 thousand at December 31, 2025, and the allowance for credit losses on loans decreased to $55,170 thousand after substantial recoveries and reserve releases tied to the loan sale. Shareholders’ equity rose to $539,146 thousand, aided by strong earnings and reduced accumulated other comprehensive loss.
Carter Bankshares, Inc. reported strong first-quarter 2026 results driven by a major credit resolution. Net income rose to $85.8 million from $9.0 million a year earlier, and basic and diluted earnings per share increased to $3.88 from $0.39.
The company completed an absolute sale of all loans reduced to judgments related to entities associated with James C. Justice II. This Transaction generated a $65.0 million gain, a $15.0 million net recovery on the judgments, and allowed release of $18.0 million of specific reserves, sharply reducing nonperforming loans.
Total assets were $4.80 billion at March 31, 2026, with portfolio loans of $3.73 billion and deposits of $4.24 billion. The allowance for credit losses on loans declined to $52.5 million from $71.5 million at year-end, reflecting the Transaction and overall credit metrics that show low charge-offs and significantly lower nonaccrual balances. Cash and cash equivalents more than doubled to $228.3 million, helped by $289.5 million of proceeds from the Transaction and portfolio loan transfers to held-for-sale.
Carter Bankshares (CARE) filed its Q3 2025 10‑Q, reporting net income of $5.4 million, or $0.24 per share. Year to date, net income was $22.9 million ($1.00 per share). Net interest income rose to $33.7 million in the quarter from $28.8 million a year ago, while provision for credit losses was $2.9 million.
Total assets reached $4.84 billion, with portfolio loans net at $3.76 billion and deposits at $4.21 billion. Accumulated other comprehensive loss improved to $46.1 million, aided by $6.2 million of quarterly unrealized gains in available‑for‑sale securities. Federal Home Loan Bank borrowings were $175.5 million.
The company completed a branch purchase in North Carolina, assuming $55.9 million of deposits and recognizing $1.2 million of goodwill and a $1.0 million core deposit intangible. Carter repurchased 809,601 shares for $14.0 million year to date, and had 22,406,406 shares outstanding at September 30, 2025. As of October 29, 2025, issued and outstanding shares were 22,087,044.